Acadia Pharmaceuticals ACAD Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $1.07B+11.9% | $957.8M+31.8% | $726.44M+40.4% | $517.24M+6.8% | ||
| $89M+8.7% | $81.84M+96.5% | $41.64M+310% | $10.17M-46.9% | ||
| $982.51M+12.2% | $875.96M+27.9% | $684.8M+35.1% | $507.07M+9.0% | ||
| 91.7%+0.2pp | 91.5%-2.8pp | 94.3%-3.8pp | 98%+2.0pp | ||
| $328.8M+8.4% | $303.25M-13.8% | $351.62M-2.8% | $361.58M+51.0% | ||
| $548.89M+12.4% | $488.43M+20.1% | $406.56M+10.2% | $369.09M-6.8% | ||
| $966.69M+33.0% | $727M-9.1% | $799.82M+8.0% | $740.83M+13.2% | ||
| $104.81M-54.6% | $230.79M— | —— | -$223.6M-31.2% | ||
| 9.8%-14.3pp | 24.1%— | —— | -43.2%-8.0pp | ||
| $31.72M+24.6% | $25.46M+47.7% | $17.23M+161% | $6.61M+1,018% | ||
| $2.37M+30.1% | $1.82M-64.3% | $5.11M+44.2% | $3.54M+73.7% | ||
| $138.9M-46.2% | $258.08M— | —— | -$213.44M-27.4% | ||
| -$252.1M-897% | $31.62M— | —— | $2.53M+621% | ||
| $391M+72.7% | $226.45M+469% | -$61.29M+71.6% | -$215.98M-28.7% | ||
| 36.5%+12.8pp | 23.6%+32.1pp | -8.4%+33.3pp | -41.8%-7.1pp | ||
| $2.30+69.1% | $1.36+458% | -$0.38+71.6% | -$1.34-27.6% | ||
| $116.57M-52.7% | $246.68M— | —— | -$221.57M-32.7% | ||
| 10.9%-14.9pp | 25.8%— | —— | -42.8%-8.3pp | ||
| $104.81M-54.6% | $230.79M— | —— | -$223.6M-31.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Acadia Pharmaceuticals's revenue?
- Acadia Pharmaceuticals (ACAD) generated $1.1B in revenue over the trailing twelve months, up 9.9% year over year.
- Is Acadia Pharmaceuticals profitable?
- Acadia Pharmaceuticals reported $375.7M in net income over the trailing twelve months, a 34.3% net margin.
- What are Acadia Pharmaceuticals's profit margins?
- Gross margin is 91.5% and operating margin is 7.4%, with a 34.3% net margin.
- What is Acadia Pharmaceuticals's earnings per share?
- Acadia Pharmaceuticals's diluted EPS over the trailing twelve months is $2.21.
- Where does Acadia Pharmaceuticals's income statement data come from?
- Every line is extracted from Acadia Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
